BioCryst to Present at Upcoming Investor Conferences
BioCryst Pharmaceuticals, Inc. (BCRX) will present at two upcoming virtual healthcare conferences, showcasing their latest developments. The presentations can be accessed via live audio webcasts on the company's website.
03/25/2024 - 04:01 PM
RESEARCH TRIANGLE PARK, N.C., March 25, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference on Thursday, March 28, 2024, at 2:30 p.m. ET and the 23rd Annual Needham Virtual Healthcare Conference on Tuesday, April 9, 2024, at 10:15 a.m. ET.
Links to the live audio webcasts and replays of the presentations may be accessed in the Investors & Media section of BioCryst’s website at http://www.biocryst.com .
About BioCryst Pharmaceuticals ® (berotralstat), the first oral, once-daily plasma kallikrein inhibitor, and is advancing a pipeline of small-molecule and protein therapies. For more information, please visit www.biocryst.com or follow us on LinkedIn.
BCRXW
Contact : jbluth@biocryst.com
When will BioCryst Pharmaceuticals present at the H.C. Wainwright conference?
BioCryst Pharmaceuticals will present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference on Thursday, March 28, 2024, at 2:30 p.m. ET.
Where can investors access the presentations?
Investors can access the live audio webcasts and replays of the presentations in the Investors & Media section of BioCryst’s website at http://www.biocryst.com.
What is the date and time of BioCryst Pharmaceuticals' presentation at the Needham Virtual Healthcare Conference?
BioCryst Pharmaceuticals will present at the 23rd Annual Needham Virtual Healthcare Conference on Tuesday, April 9, 2024, at 10:15 a.m. ET.
Biocryst Pharmaceuticals Inc.
BCRX Rankings
#4914 Ranked by Stock Gains
BCRX Stock Data
Industry
Biological Product (except Diagnostic) Manufacturing
Sector
Manufacturing
Tags
Health Technology, Biotechnology, Manufacturing, Biological Product (except Diagnostic) Manufacturing
Country
US
City
Durham
About BCRX
biocryst pharmaceuticals, a biotechnology company, designs, optimizes and develops novel small-molecule drugs that block key enzymes involved in infectious and rare diseases. founded in 1986, biocryst has more than 50 employees and is experiencing continued growth. the company’s headquarters are located in research triangle park, north carolina and its discovery center of excellence is in birmingham, alabama. with expertise in drug discovery, clinical development, regulatory affairs and product commercialization, we continue to advance our clinical programs and to generate new compounds from our own discovery engine. we are proud of our culture of engagement and accountability that rewards people for innovative thinking and achievement of key objectives. the commitment of biocryst remains unchanged. we continue to be passionate about developing and marketing novel therapeutics for patients with rare and serious diseases.
